Glaukos Corp Files 2024 10-K

Ticker: GKOS · Form: 10-K · Filed: Feb 25, 2025 · CIK: 1192448

Sentiment: neutral

Topics: 10-K, annual-report, healthcare, medical-devices

TL;DR

Glaukos 2024 10-K is in. Full financials and strategy details out now.

AI Summary

Glaukos Corporation filed its 2024 10-K on February 25, 2025, reporting on its fiscal year ending December 31, 2024. The company, a leader in ophthalmic medical devices, detailed its financial performance and strategic initiatives. Key financial data and operational highlights for the period are presented within the filing.

Why It Matters

This filing provides investors and stakeholders with a comprehensive overview of Glaukos' financial health, operational performance, and strategic direction for the fiscal year 2024.

Risk Assessment

Risk Level: medium — The filing is a standard annual report and does not inherently indicate new or elevated risks.

Key Numbers

Key Players & Entities

FAQ

What is the primary business of Glaukos Corporation?

Glaukos Corporation is primarily involved in the surgical and medical instruments and apparatus industry, with a focus on ophthalmic medical devices.

When did Glaukos Corporation's fiscal year end for this report?

The fiscal year end for this report was December 31, 2024.

On what date was this 10-K filing submitted?

This 10-K filing was submitted on February 25, 2025.

What is the company's business address?

The business address is 1 Glaukos Way, Aliso Viejo, CA 92656.

What is the SEC file number for Glaukos Corporation?

The SEC file number for Glaukos Corporation is 001-37463.

Filing Details

This Form 10-K (Form 10-K) was filed with the SEC on February 25, 2025 regarding GLAUKOS Corp (GKOS).

View full filing on EDGAR

View Full Filing

View this 10-K filing on SEC EDGAR

View on Read The Filing